Mutations in the BRCA2 gene significantly increase the risk of developing breast and ovarian cancer. Women with BRCA2 mutations have a 45-85% lifetime risk of developing breast cancer and a 10-30% risk for ovarian cancer. Men with BRCA2 mutations also face increased risks, particularly for prostate and breast cancer.
